过敏性鼻炎患者在不同时间段应用糠酸莫米松联合盐酸氮卓斯汀的疗效评价 Efficacy Assessment on Allergic Rhinitis Treated by Mometasone Furoate and Azelastine Hydrochloride at Different Times
Derendorf H,Munzel U,Petzold U,et al.Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02,a novel aqueous nasal spray[J].Br J Clin Pharmacol,2012,74(1):125-133.
[2]
Klimek L,Bachert C,Mosges R,et al.Effectiveness of MP29-02for the treatment of allergic rhinitis in reallife:results from a noninterventional study[J].Allergy Asthma Proc,2015,36(1):40-47.
[3]
Bousquet J,Bachert C,Bernstein J,et al.Advances in pharmacotherapy for the treatment of allergic rhinitis;MP29-02(a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system)fills the gaps[J].Expert Opin Pharmacother,2015,16(6):913-928.
[4]
Wolthers OD.New patents of fixed combinations of nasal antihistamines and corticosteroids in allergic rhinitis[J].Recent Pat Inflamm Allergy Drug Discov,2013,7(3):223-228.
[5]
Berger WE,Shah S,Lieberman P,et al.Long-term,randomized safety study of MP29-02(a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system)in subjects with chronic rhinitis[J].J Allergy Clin Immunol Pract,2014,2(2):179-185.
